Login

Reflecting on My Failure to Make Gumroad a Billion Dollar Company|Sahil Lavingia,Founder,SHL Capital 00:10:00

Share On Facebook Share On Twitter

Founder and CEO of Gumroad. Previously, he was early at Pinterest.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Leon Coetzer is the Chief Executive Officer of Jubilee Metals Group, leveraging his chemical engineering background and extensive experience in the mining industry to lead a company focused on sustainable metal recovery and community development.|Leon Coe
00:10:00
Revolutionizing Mining with Real-Time Data and Automation: The Impact of Olga and Carbon Scout
00:10:00
Enhancing Supply Chain Agility Through Digital Innovation and Global Networking
00:10:00
Middle Market M&A: Insights on Valuations and Activity Trends for 2014
00:10:00
VC fund firm focused exclusively on funding entrepreneurs with a vision|Michael Staton,Venture Partner,Learn Capital
00:10:00
UiPath (PATH) stock plummets following earnings report and CEO departure, as covered by Morningstar, Inc.
00:00:00
Imugene sees positive early signals in Phase 1 VAXINIA study - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
Chris Lee Discusses Exits and Trends in Private Equity
00:10:00
Q1 2024 Investment Review and Outlook | Ben Hockema, Illuminate Wealth Management
00:10:00
Unlocking Wealth Potential: The Strategic Advantage of Roth Conversions by Raquel Hinman | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:10:00
Alpha Financial Markets Consulting PLC's outgoing CEO Euan Fraser and incoming CEO Luc Baqué discuss the leadership transition with Proactive's Thomas Warner.|Luc is Chief Executive Officer of Alpha
00:10:00
Navigating Post-COVID Economic Opportunities: Insights from Savvas Savouri | Chief Economist, Toscafund

© 2017 - Neuhu+